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Background: The AIN-93 diet was proposed by the American Institute of Nutrition with the objective of
standardising studies in experimental nutrition. Our objective was to analyze the effects of AIN-93 diet after
myocardial infarction in rats.
Methods: Post weaning, the animals were divided into two groups: control (C, n=62), fed the standard diet of
our laboratory (Labina); AIN-93 Group (n=70), fed the AIN-93 diet. Achieving 250 g, the animals were
subjected to myocardial infarction.
Results: Earlymortalitywas increased inAIN-93animals, associatedwith lower serumlevels of calcium,magnesium,
potassium, sodium, and phosphorus. On the other hand, after 90 days, AIN-93 showed smaller normalized left
ventricular dimensions. The caloric and carbohydrate intakewas smaller, but the fat intakewashigher inAIN-93 rats.
AIN-93 group also showed increased levels of β-hydroxyacylcoenzyme A dehydrogenase and citrate synthase. In
addition, serum levels of insulin and cardiac levels ofmalondialdehyde,metalloproteinases-2 and -9, and TNF-α and
IFN-γwere decreased in the AIN-93 group.
Conclusion: AIN-93 diet increased early mortality, while attenuated the chronic remodeling process after
experimental coronary occlusion. Therefore, this diet has biological effects and should be use with attention in this
model.
© 2010 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
Cardiac remodeling may be deﬁned as changes in the size, geometry,
shape, composition, and function of the heart. This process occurs in
response to several stimuli including both pressure and volume overload,
myocardial infarction, and genetic alterations. Importantly, ventricular
remodeling is now recognized as a signiﬁcant pathological process that
results in progressive ventricular dysfunction and cardiovascular death
[1–4].
The model of cardiac injury in rats has broadened the knowledge of
the pathophysiology of remodeling. Furthermore, it was possible to
identify therapeutic strategies that reduce remodeling. Among these
strategies is the manipulation of dietary components [5–8]. In different
models of cardiac injury, the literature presents several studies in this
direction, and typically the standard diet used is AIN-93.ica, Faculdade de Medicina de
8-000. Tel.: +55 14 38222969;
ff).
e Elsevier OA license.The AIN-93 diet was proposed by the American Institute of
Nutrition with the objective of standardising studies in experimental
nutrition. The intent of standardising diets for laboratories was to
reduce the variations inherent in cereal-based diets and facilitate
interpretations of results from different laboratories [9]. However, the
effects of AIN-93 diet on mortality, morphological and functional
cardiac variables after myocardial infarction are unknown. Therefore,
our objective was to analyze the effects of AIN-93 diet on mortality
and the remodeling process after myocardial infarction in rats.
2. Materials and methods
All experiments and procedures were performed in accordance with NIH guide-
lines for the Care and Use of Laboratory Animals and were approved by the Animal
Ethics Committee of our Institution.
2.1. Study design
After weaning, male Wistar rats were randomly divided into two groups: control
(C, n=62), animals fed the standard diet of our laboratory (Labina); AIN-93 Group
(n=70), animals fed the AIN-93 G diet. The diet constitutions are shown in Table 1.
When a weight of 200–250 g had been reached, the animals were submitted to
Table 1
Diet constitutions.
Control AIN-93
Boron (mg/kg) 14 6.0
Calcium (mg/kg) 16000 6000
Copper (mg/kg) 35 7
Chromium (mg/kg) 2.9 2.0
Cobalt (mg/kg) 1.4 0.01
Cadmium (mg/kg) 0.01 0.007
Lead (mg/kg) 0.1 0.1
Phosphorus (mg/kg) 9300 3500
Iron (mg/kg) 271 83
Manganese (mg/kg) 115 9.0
Magnesium (mg/kg) 290 500
Molybdenum (mg/kg) 2.0 0.02
Mercury 0.04 0.06
Níckel (mg/kg) 1.8 1.0
Sodium (mg/kg) 40000 36000
Potassium (mg/kg) 12000 4000
Selenium (mg/kg) 0.096 0.15
Silicon (mg/kg) 2.0 1.6
Zinc (mg/kg) 370 58
Carbohydrates (%) 68 64
Fat (%) 7.2 16.7
Protein (%) 24.8 19.3
Total energy, kcal/100 g 383 427
266 L.P. Ardisson et al. / International Journal of Cardiology 156 (2012) 265–269experimental myocardial infarction. Food and water were supplied ad libitum. The
planned observation period was 90 days, when morphological, biochemical and
functional analyses were performed. All procedures were carried out by observers
who were blinded to the animal's data.
2.2. Coronary artery ligation
The myocardial infarction was produced as previously described [10,11]. In brief,
the rats were anesthetised with intramuscular injection of ketamine (50 mg/kg), and
after a left thoracotomy, the heart was exteriorised. The left atrium was retracted to
facilitate ligation of the left coronary artery with 5-0 mononylon between the
pulmonary outﬂow tract and the left atrium. The heart was then replaced in the thorax;
as the thoracotomy was closed, the lungs were inﬂated by positive pressure. The rats
were housed in a temperature-controlled room (24 °C) with a 12-hour light:dark cycle.
The vitality of the animals was veriﬁed every 12 h during the ﬁrst 24 h after surgery and
daily afterwards. The early period was deﬁned as the ﬁrst 24 h.
2.3. Echocardiographic study
After 3 months, all animals were weighed and evaluated by a transthoracic
echocardiographic exam [10,11]. The exams were performed using a commercially
available echocardiographic machine (Philips model TDI 5000) equipped with a
12 MHz phased array transducer. Rats were lightly anaesthetised by intramuscular
injection of a solution composed of ketamine (50 mg/kg) plus xylazine (1 mg/kg). All
measurements were obtained by the same observer, according to the leading-edge
method recommended by the American Society of Echocardiography/ European
Association of Echocardiography [12]. Measurements represented the mean of at
least ﬁve consecutive cardiac cycles. LV end-diastolic dimension (LVDD) and posterior
wall thickness (LVWT) were measured at maximal diastolic dimension, whereas the
end-systolic dimension (LVSD) was taken at maximal anterior motion of the posterior
wall. The left atrium was measured at its maximal diameter and the aorta at end of
diastole. After that, end-systolic and end-diastolic endocardial borders were traced in
both short-axis and long-axis views. The end-systolic and end-diastolic cavity areas
were calculated as the sum of the areas from both the short- and long-axis views in
diastole (SumD) and systole (SumS), respectively. Fractional area change (FAC) was
calculated from the composite cavity areas as: FAC=(SumD−SumS)/SumD. The
diastolic transmitral ﬂow velocities (E and A velocities) were obtained from the apical
four-chamber view. The E/A ratio, the isovolumetric relaxation time, and the
isovolumetric relaxation time normalized for heart rate (TRIV/RR0,5) were used as
indices of LV diastolic function.
2.4. Morphometric analysis
At the completion of the functional study, the right and left ventricles (including
the interventricular septum) were dissected, separated, and weighed.
The morphometric analysis of the myocardium was performed as previously described
[13]. Transverse 3 mm-thick sections of LV were ﬁxed in 10% buffered formalin and
embedded in parafﬁn. Myocyte cross-sectional area (CSA) in the non-infarcted area was
determined for at least 100 myocytes per slide stained with hematoxylin–eosin. The
measurements were performed using a Leica microscope (lens magniﬁcation 400×)attached to a video camera and connected to a personal computer equipped with image
analyzer software (Image-Pro Plus 3.0, Media Cybernetics, Silver Spring, MD, USA). CSA was
measured with a digitising pad, and the selected cells were transversely cut with the
nucleus clearly identiﬁed in the centre of the myocyte. Interstitial collagen volume fraction
(IC) was determined in the non-infarcted area for the entire picrosirius red-stained cardiac
section using an automated image analyzer (Image-Pro Plus 3.0, Media Cybernetics). An
average of 35 microscopic ﬁelds were analyzed with a 40× lens. Perivascular collagen was
excluded from this analysis. The lengths of the infarcted and viable muscle for both the
endocardial and epicardial circumferences were determined by planimetry. Infarct size was
calculated by dividing the endocardial and epicardial circumferences of the infarcted area by
total epicardial and endocardial ventricular circumferences. Measurements were performed
on midventricular slices (5–6mm from the apex), under the assumption that the left
midventricular slice showed a close linear relation with the sum of the area measurements
from all heart slices [14].
2.5. Determination of serum minerals and insulin
Immediately after the death following the experimental myocardial infarction or
after euthanasia three months after the coronary occlusion, serumminerals and insulin
were measured in all animals. Serum insulin concentration was measured by
rat-speciﬁc ELISA kit according to the manufacturer's instructions (Linco-Research
Inc, USA, Cat no EZRMI-13K).
2.6. Metalloproteinase-2 and -9 activity
The metalloproteinase (MMP)-2 and -9 activity was determined in the non-infarcted
area as reported by Tyagi et al. [15]. In brief, samples for analysis were prepared by dilution
in extraction sample buffer consisting of 50 mM Tris, pH 7.4; 0.2 M NaCl; 0.1% Triton X and
10mM CaCl2. Protein was quantiﬁed in spectrophotometer and 30 ug of each sample was
loaded into the wells of 8% SDS-polyacrylamide containing 1% gelatin. Electrophoresis was
carried out in a Bio-Rad apparatus at 100 V for 1.5 h, at 8 °C. The gel was removed and
washed with 2.5% Triton-X-100 and then washed with 50mM Tris pH 8.4. The gel was then
incubated at 37 °C overnight in activation solution consisting of 50 mM Tris pH 8.4; 5 mM
CaCl2 and Zn Cl2. The staining was performed for 1 h with 2.5% comassie blue and
destaining in 30% methanol and 10% acetic acid until clear bands over a dark background
were observed. The gels were photographed and the intensity of gelatinolytic action (clear
bands) analyzed in UVP, UV,White Darkhon image analyzer. The optic density, measured in
pixels, of each metaloproteinases band was quantiﬁed by Gel pro-3.1 software.
2.7. Evaluation of cytokine production
Brieﬂy 60 mg of cardiac tissue of the non-infarcted area was homogenised and
solubilised in 50 mM potassium phosphate buffer, pH 7.4; 0.3 M sucrose; 0.5 mM DTT;
1 mM EDTA, pH 8.0; 0.3 mM PMSF; 10 mM NaF, and 1:100 protease inhibitor. Cytokine
levels in cardiac homogenate were evaluated by ELISA according to the manufacturer's
instructions (R & D Systems, Minneapolis, MN, USA). Sensitivities of ELISA for IFN-γ and
TNF-α were 19 and 31 pg/ml respectively.
2.8. Energy metabolism
LV samples of the non-infarcted area (200mg)were weighed and homogenised in 5 ml
of cold phosphate buffer (0.1 M, pH 7.4) containing 1 mM of ethylenediaminetetraacetic
acid (EDTA). Tissue homogenates were prepared in a motor-driven Teﬂon-glass Potter-
Elvehjem tissue homogeniser (1 min, 1000 rpm) immersed in ice water. The homogenate
was centrifuged at 10,000 rpm for 15min. The supernatant was analyzed for total protein,
lactate dehydrogenase (LDH; E.C.1.1.1.27.), β-hydroxyacylcoenzyme A dehydrogenase
(HADH; E.C.1.1.1.35.) and citrate synthase (CS; E.C.4.1.3.7.). The assay medium for LDH
contained 50mM of Tris–HCl buffer (pH 7.5), 0.15 mM of nicotinamide adenine
dinucleotide in reduced form and 1mM of pyruvate (omitted in the C group). For CS
activity the assay medium consisted of 50 mMof Tris–HCl buffer (pH 8.1), 0.3 mMof acetyl-
coenzyme A, 0.1 mM of 5,5-dithio-bis-2-nitrobenzoic (DTNB) and 0.5 mM oxaloacetate
(omitted in the group C). HADH was assayed in a medium containing 50mM of Tris–HCl
buffer (pH 7.0), 5 mM of EDTA, 0.45 mM of reduced nicotinamide adenine dinucleotide and
0.1 mM of acetyl-coenzyme A [16].
2.9. Measurements of lipid peroxidation
Lipid peroxidation in the non-infarcted area was assessed by measuring
malondialdehyde (MDA) using an HPLC system as reported previously [17]. Brieﬂy,
plasma or plasma incubated with 5 mM AMVN at 42 °C for 2 h was treated with BHT
(5% in EtOH), followed by protein precipitation using TCA (10% w/v). The mixture was
allowed to react with TBA (0.4% w/v, in an acetate buffer, pH 3.5) and analyzed for
MDA-TBA adducts by an HPLC system equipped with a Pecosphere-3 C18 column
(83×4.6 mm) and a ﬂuorescence detector (Waters 2475 multi λ), set, respectively, at
Ex 515 nm and Em 553 nm. The HPLC mobile phase was 20 mM potassium phosphate
buffer/acetonitrile (80:20, v/v) and the ﬂow rate was set at 0.8 ml/min. The lower
detection limit on the column is 0.2 pmol for the MDA-TBA adduct. Endogenous MDA
and AMVN induced MDA were determined to evaluate the lipid peroxidation and
plasma oxidation susceptibility, respectively.
267L.P. Ardisson et al. / International Journal of Cardiology 156 (2012) 265–2692.10. Statistical analysis
Comparisons between groups were made by Student's t test for parameters with
normal distribution. Otherwise, comparisons between groups were made using the
Mann–Whitney U test. Data were expressed as mean±SD or medians (including the
lower quartile and upper quartile). The χ2 test was used to compare categorical
variables. The mortality was analyzed by the Kaplan–Meier curve followed by log-rank
test. Data analysis was carried out with SigmaStat for Windows v2.03 (SPSS Inc,
Chicago, IL). The signiﬁcance level was considered 5%.3. Results
Tail cuff blood pressure assessed two weeks prior to surgery was
similar between groups (C=130 (120–130) mm Hg; AIN-93=130
(120–130) mmHg; p=0.964). Also, there was no difference in infarct
size (C=29.7±17.2%; AIN-93=32.6±18.4%; p=0.677).
Considering the entire observation period, mortality was higher in
AIN-93 animals (C=66%; AIN-93=85.7%; p=0.017; Fig. 1). However,
this was caused by the increased mortality in the early (≤24 h) period
(C=61%; AIN-93=80%; pb0.001), since chronic mortality (24 h to
three months) was the same in both groups (C=4.8%; AIN-93=5.7%;
p=0.138). AIN-93 showed lower normalized left ventricular diastolic
diameter, as well as diastolic and systolic normalized LV areas, compared
to controls. On the other hand, AIN-93 showed higher aortic diameter
(C=3.3±0.3 mm; AIN-93=3.6±0.3 mm; p=0.03). As to the diastolic
function indices, the AIN-93 group presented smaller E wave, and higher
TRIV/RR0,5, suggesting improved diastolic function [18]. There were no
differences in systolic function parameters (Table 2).
Morphological data showed that the AIN-93 diet prevented
myocardial water accumulation (C=75 (74-76) %; AIN93=73.7
(67–74) %; p=0.006). Furthermore, that diet was associated with a
strong tendency toward smaller interstitial collagen volume fraction
in comparisonwith control rat chow (C=4.4 (2.9–7.5) %; AIN93=2.9
(2.0–5.0) %; p=0.07). There were no differences in the other
variables.
AIN-93 animals showed lower serum levels of calcium (C=10.6±
0.3 mg/dl; AIN-93=9.96±0.37 mg/dl; p=0.019), magnesium
(C=2.7±0.15 mg/dl; AIN-93=1.9±0.12 mg/dl; p=0.001), po-
tassium (C=4.44±0.3 mmol/l; AIN-93=3.04±0.29 mmol/l;
p=0.001), sodium (C=138±2.2 mmol/l; AIN-93=128±2.2 mmol/l;Time (days)
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Fig. 1. Kaplan–Meyer curve considering the cumulative percent survival after
myocardial infarction of rats fed with AIN-93 diet or fed with control (C) diet;
p=0.017.p=0.001), and phosphorus (C=7.4±0.8 mg/dl; AIN-93=5.6±
0.4 mg/dl; p=0.019) in relation to control animals.
The diet intakewas smaller in the AIN-93 group (C=22.8 (22.3–23.4)
g/day; AIN-93=16.6 (15.9–17.3) g/day; p=0.001). Likewise, the caloric
(C=87.1 (85.1–89.3) kcal/day; AIN-93=70.8 (67.8–73.8) kcal/day;
pb0.001), carbohydrate (C=13.4 (13.1–13.8) g/day; AIN-93=10.1
(9.7–10.5) g/day; pb0.001), and protein (C=5.3 (5.2–5.5) g/day;
AIN-93=3.4 (3.2–3.5) g/day; pb0.001) intakes were smaller in AIN-93
animals . On the other hand, the fat intake was higher in AIN-93 rats
(C=0.34 (0.33–0.35); AIN-93=1.05 (1.01–1.10); pb0.001).
Biochemical data are shown in Table 3. The AIN-93 diet was
associated with decreased MMP-2 and MMP-9 values of the active-
inactive ratio. In relation to energetic metabolism, the AIN-93 group
showed increased levels of β-hydroxyacylcoenzyme A dehydrogenase,
citrate synthase as well as a strong tendency toward increased levels of
lactate dehydrogenase. On the other hand, AIN-93 produced decreased
levels of insulin, at the limit of statistical signiﬁcance. As to cytokine
production, the AIN-93 group showed decreased cardiac levels of IFN-γ
and trended strongly toward diminished cardiac levels of TNF-α.
Likewise, the MDA levels were lower in the AIN-93 group.
4. Discussion
The objective of our study was to analyze the effects of the AIN-93
diet on the remodeling process and mortality after myocardial
infarction in rats. Our results suggest that the AIN-93 diet increased
early mortality after experimental coronary occlusion. However,
afterwards, AIN-93 attenuated the remodeling process.
It is well known that mortality within the ﬁrst 24 h after surgery is
usually high, approximately 40–60% [19,20]. Although several causes
such as pneumothorax, respiratory depression, heart failure and acute
pulmonary edema are related to this event, it seems that malignant
arrhythmias play a major role. In fact, Opitz et al. found 65% mortality
in the ﬁrst 48 h after the infarction. Through continuous monitoring,
the authors demonstrated that 96% of the animals submitted to the
acute MI presented hundreds of episodes of ventricular tachycardia
and at least 20 episodes of ventricular ﬁbrillation. Additionally, two
distinct periods of arrhythmia were demonstrated: the initial period
included the ﬁrst 30 min after the coronary occlusion and the second,
responsible for 65% of the deaths, comprised the period between 1.5
and 9 h after the infarction [21]. Regarding the chronic period after MI,
the mortality observed in this model is extremely variable, with the
size of the infarction being themain determinant of this event. Indeed,
Pfeffer et al., following infarcted animals for a period of one year,
veriﬁed that for small (5–19.9% of the left ventricle), moderate
(20–39.9%) and large infarctions (N40%), the respective mortality
rates were around 50%, 75% and 85% [20].
The noteworthy ﬁnding in the present study was that the AIN-93
diet was associated with increasedmortality within the ﬁrst 24 h after
myocardial infarction. Furthermore, in the AIN-93 animals this
phenomenonwas associated with decreased serum levels of minerals,
namely, potassium, phosphorus and magnesium. Importantly, the
decreased levels of these electrolytes are associated with higher
prevalence of arrhythmias after myocardial infarction. In addition, the
correction of these abnormalities in serum electrolytes decreased the
arrhythmias [22]. Therefore, it is reasonable to assume that the
increased mortality in the AIN-93 animals early after myocardial
infarction might be a consequence of increased fatal arrhythmias due
to decreased electrolyte levels. However, we should to consider that
we did not analyze arrhythmias or electrolyte levels in the chronic
phase after MI. To the best of our knowledge, this is the ﬁrst study to
demonstrate the adverse effect of the AIN-93 diet early after
experimental infarction in rats.
Another relevant issue of our studywas that AIN-93modulated the
remodeling process in the chronic phase following myocardial
infarction. This phenomenon was characterized mainly by a decrease
Table 2
Ecocardiographic data.
Variables C (n=21) AIN-93 (n=10) P
BW (g) 453±54 486±60 0.14
HR (beats/min) 287±39 306±60 0.32
LVDD/BW (mm/kg) 24.0±3.6 20.2±2.6 0.008
SA/BW short axis (cm2/kg) 1.38 (1.3–1.4) 1.29 (0.93–1.5) 0.52
DA/BW short axis (cm2/kg) 2.0 (1.8–2.2) 1.8 (1.4–2.0) 0.18
SA/BW long axis (cm2/kg) 2.2±0.5 1.7±0.4 0.02
DA/BW long axis (cm2/kg) 2.7±0.5 2.2±0.4 0.02
E (cm/s) 101±17 82±19 0.009
A (cm/s) 37 (16–78) 49 (20–62) 0.73
E/A 2.0 (1.2–6.1) 1.3 (1.1–5.0) 0.78
TRIV (ms) 27.9±6.7 32.3 ±3.2 0.07
TRIV/RR0,5 (ms) 58 (55–70) 66 (64–80) 0.04
FAC 20.6±6.3 25.5±9.3 0.09
C: animals fed control diet; AIN-93: animals fed AIN-93 diet; BW: body weight; HR: heart rate; LV: left ventricle; LVDD: LV end-diastolic dimension; LVSD: LV end-systolic
dimension; LVWT: LV posterior wall thickness; E: peak velocity of early ventricular ﬁlling; A: peak velocity of transmitral ﬂow during atrial contraction; TRIV: isovolumetric
relaxation time; TRIV/RR0,5: isovolumetric relaxation time normalized for heart rate; FAC: fractional area change. Data are expressed as mean±SD or medians (including the lower
quartile and upper quartile).
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ventricular mass, volume, and geometry after cardiac injury can be
interpreted as an expression of the remodeling process. Regardless of
the complexity of this process, after MI the term remodeling is
frequently used as a synonym for ventricular dilation [1–4].
Consequently, our data indicate that the AIN-93 diet attenuated
ventricular remodeling after coronary occlusion.
The remodeling process following myocardial infarction is also
associated with extracellular matrix alterations. Extracellular matrix
degradation by MMP has been associated with slippage of myocyte
fascicles and left ventricular wall thinning. However, it has been
reported after MI that extracellular matrix degradation, paralleled by
an abnormal collagen accumulation, resulted in ﬁbrosis in the non-
infarcted areas [23]. Importantly, this abnormal collagen accumula-
tion is associated with myocardial dysfunction, beginning with
diastolic dysfunction followed by abnormalities in systolic function
[24,25]. Corroborating this concept, in our study the AIN-93 diet was
associated with diminished collagen and improvement in diastolic
function. In normal rats, smaller E waves and larger TRIV/RR suggest
worse diastolic function. However, infarcted rats presented higher E
wave and smaller TRIV/RR in comparison with controls, indicating a
restrictive pattern. In this study, only infarcted animals were
analyzed. Thus, in this situation, smaller E wave and higher TRIV/
RR0,5, as presented by AIN-93 group, are related to improved diastolic
function [18]. Likewise, this phenomenon was associated with
decreased MMP activity, since the AIN-93 diet reduced the activity
of both MMP-2 and MMP-9. Therefore, at this time, the beneﬁcial
effects of AIN-93 diet can be explained by MMP alterations.Table 3
Biochemical data.
Variables C (n=5) AIN-93 (n=5) P
MMP-2 0.93±0.20 0.62±0.18 0.045
MMP-9 1.00±0.29 0.48±0.19 0.014
TNF-α (pg/mg protein) 187±38 114±43 0.07
IFN-γ (pg/mg protein) 170±21 113±35 0.03
Insulin (ng/dl) 3.32±2.00 1.70±1.50 0.05
HADH (nmol/mg/tissue) 7.6±1.2 12±3.9 0.04
LD (nmol/mg/protein) 651±149 801±104 0.07
CS (nmol/mg/protein) 277±18 352±26 0.003
MDA (nmol/mg protein) 5.32±2.3 2.61±1.2 0.048
C: animals fed control diet; AIN-93: animals fed AIN-93 diet; MMP-2: metalloproteinase-2
activity/latent ratio; MMP-9: metalloproteinase-9 activity/latent ratio; IFN-γ: interferon-γ;
TNF-α: tumor necrosis factor-α; HADH: β-hydroxyacylcoenzyme A dehydrogenase; LD:
lactate dehydrogenase; CS: citrate synthase; MDA: malondialdehyde. Data are expressed as
mean±SD.The potential impact of dietary composition on cardiac remodeling
has not been well studied. However, some experimental studies,
utilizing the hypertension model, have shown that increased dietary
lipid intake and reduced carbohydrate intake can reduce cardiac
hypertrophy, ventricular remodeling and cardiac dysfunction, which
are associated with reduced insulin levels [5,26,27]. It is accepted that
insulin can activate intracellular signalling pathways involved as a
trigger and modulator of the remodeling process [28]. In concordance
with this assumption, in our study, the animals fed the AIN-93 diet
presented higher lipid, but smaller carbohydrate and caloric intake.
Importantly, this ﬁnding was associated with reduced insulin levels,
in comparison to control animals.
These differences in macronutrient compositions in the AIN-93 diet
could inﬂuence oxidative stress, inﬂammation and energetic metabolism.
Furthermore, oxidative stress, another potential mechanism involved in
the remodelingprocess, is also increased afterMI. It is accepted that oneof
the principal consequences of the oxidative stress is lipoperoxidation. In
the acute phase, oxidative stress contributes to the inﬂammatory process
and healing of the infarcted region. Chronically, however, oxidative stress
would induce remodeling since it results in mitochondrial dysfunction,
metalloproteinase activation, ﬁbrosis, hypertrophy and cell death [29,30].
Based on this assumption, the attenuation of cardiac remodeling by
AIN-93 was associated with decreased MDA concentrations. Therefore,
our study suggests that the protective effects of AIN-93 include oxidative
stress attenuation.
In the context of the inﬂammatory process, increased cytokine
production can modulate left ventricular remodeling. Indeed, increased
IFN-γ and, especially, TNF-α levels are associated with left ventricular
dysfunction, cachexia, fetal gene-program activation, apoptosis, hy-
pertrophy, and ﬁbrosis [31]. Likewise, cardiac remodeling can be
associated with abnormalities in myocardial energetic metabolism. In
different models, the morphological and functional alterations are
related to increased utilization of glucose as substrate and diminished
cardiac substrate utilization [32]. In our study, the remodeling
attenuation induced by AIN-93 diet was associated with decreased
IFN-γ and TNF-α levels. In addition, there was an increase in both
carbohydrate (assessed by lactate dehydrogenase) and oxidation of
fatty acids (assessed by β-hydroxyacylcoenzyme A dehydrogenase),
associated with elevated citrate synthase levels, suggesting increased
cardiac metabolic substrate utilization. Therefore, these inﬂammatory
and metabolic changes are thought to contribute to the attenuation of
AIN-93-induced cardiac remodeling.
Potential limitations should be considered in our study. The
differences in mortality between the groups could suggest a survivor
bias in the measurement made at 3 months. However, there were no
differences in the infarct size among the survivors. Consequently, we
strongly believe that this bias did not occur in our study. In addition,
269L.P. Ardisson et al. / International Journal of Cardiology 156 (2012) 265–269we did not assess the infarct size in the animals that died before the
end of the protocol. Therefore, larger infarct size could explain the
increased mortality observed in AIN-93 group as compared with
control.
Our study has relevant implications. To identify pathophysiologic
mechanisms or therapeutic strategies that reduce remodeling, it is
necessary that the diet consumed by the animals does not interfere
with this process. However, our results evidenced that this diet has
biological effects in a rat model of myocardial infarction. Therefore,
the AIN-93 diet should be used with attention in this model.
In conclusion, the AIN-93 diet increased early mortality after
experimental coronary occlusion in rats, which was associated with
decreased serum levels of different minerals. Afterwards, AIN-93
attenuated the remodeling process by decreasing insulinemia,
inﬂammatory cytokines, the activity of MMP-2 and -9, and oxidative
stress, while increasing cardiac metabolic substrate.
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